| Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance NJ White, W Pongtavornpinyo, RJ Maude, S Saralamba, R Aguas, ... Malaria journal 8, 1-18, 2009 | 232 | 2009 |
| The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia RJ Maude, W Pontavornpinyo, S Saralamba, R Aguas, S Yeung, ... Malaria journal 8, 1-7, 2009 | 221 | 2009 |
| Intrahost modeling of artemisinin resistance in Plasmodium falciparum S Saralamba, W Pan-Ngum, RJ Maude, SJ Lee, J Tarning, N Lindegårdh, ... Proceedings of the national academy of sciences 108 (1), 397-402, 2011 | 189 | 2011 |
| The role of simple mathematical models in malaria elimination strategy design LJ White, RJ Maude, W Pongtavornpinyo, S Saralamba, R Aguas, ... Malaria journal 8, 1-10, 2009 | 109 | 2009 |
| Probability of emergence of antimalarial resistance in different stages of the parasite life cycle W Pongtavornpinyo, IM Hastings, A Dondorp, LJ White, RJ Maude, ... Evolutionary applications 2 (1), 52-61, 2009 | 54 | 2009 |
| Assessing the suitability of mitochondrial and nuclear DNA genetic markers for molecular systematics and species identification of helminths AHE Chan, K Chaisiri, S Saralamba, S Morand, U Thaenkham Parasites & Vectors 14 (1), 233, 2021 | 48 | 2021 |
| Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach W Pan-Ngum, T Kinyanjui, M Kiti, S Taylor, JF Toussaint, S Saralamba, ... Vaccine 35 (2), 403-409, 2017 | 35 | 2017 |
| Determinants of MDA impact and designing MDAs towards malaria elimination B Gao, S Saralamba, Y Lubell, LJ White, AM Dondorp, R Aguas Elife 9, e51773, 2020 | 33 | 2020 |
| The role of mathematical modelling in guiding the science and economics of malaria elimination RJ Maude, Y Lubell, D Socheat, S Yeung, S Saralamba, ... International health 2 (4), 239-246, 2010 | 30 | 2010 |
| Malaria elimination transmission and costing in the Asia-Pacific: a multi-species dynamic transmission model SP Silal, R Shretta, O Celhay, CE Gran Mercado, S Saralamba, RJ Maude, ... Wellcome Open Research 4, 2019 | 27 | 2019 |
| Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data XHS Chan, YN Win, IL Haeusler, JY Tan, S Loganathan, S Saralamba, ... PLoS medicine 17 (3), e1003040, 2020 | 26 | 2020 |
| The potential use of mitochondrial ribosomal genes (12S and 16S) in DNA barcoding and phylogenetic analysis of trematodes AHE Chan, N Saralamba, S Saralamba, J Ruangsittichai, U Thaenkham BMC genomics 23 (1), 104, 2022 | 19 | 2022 |
| Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design STT Tun, L Von Seidlein, T Pongvongsa, M Mayxay, S Saralamba, ... Malaria journal 16, 1-12, 2017 | 19 | 2017 |
| A dynamic stress model explains the delayed drug effect in artemisinin treatment of Plasmodium falciparum P Cao, N Klonis, S Zaloumis, C Dogovski, SC Xie, S Saralamba, LJ White, ... Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 00618-17, 2017 | 13 | 2017 |
| Modelling malaria elimination on the internet RJ Maude, S Saralamba, A Lewis, D Sherwood, NJ White, NPJ Day, ... Malaria journal 10, 1-5, 2011 | 10 | 2011 |
| Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic Y Wang, N Luangasanatip, W Pan–ngum, W Isaranuwatchai, J Prawjaeng, ... The European Journal of Health Economics 24 (5), 735-748, 2023 | 9 | 2023 |
| The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?) RJ Maude, W Pontavornpinyo, S Saralamba, AM Dondorp, NPJ Day, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 103 (6 …, 2009 | 9 | 2009 |
| Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application STT Tun, Y Lubell, AM Dondorp, T Fieldman, KM Tun, O Celhay, XH Chan, ... Plos one 12 (5), e0177840, 2017 | 6 | 2017 |
| Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting T Kinyanjui, W Pan-Ngum, S Saralamba, S Taylor, L White, DJ Nokes Vaccine: X 4, 100055, 2020 | 5 | 2020 |
| Classification of elderly pain severity from automated video clip facial action unit analysis: A study from a Thai data repository P Gomutbutra, A Kittisares, A Sanguansri, N Choosri, P Sawaddiruk, ... Frontiers in Artificial Intelligence 5, 942248, 2022 | 4 | 2022 |
Lisa J WhiteProfessor of Modelling and Epidemiology, University of OxfordVerifierad e-postadress på biology.ox.ac.uk
